Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?
about
Lithium for schizophreniaSignificant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis StudyOff-label use of sodium valproate for schizophreniaCarbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.Histone Posttranslational Modifications in Schizophrenia.Elderly patients with schizophrenia and depression: diagnosis and treatmentTeratogenic risk and contraceptive counselling in psychiatric practice: analysis of anticonvulsant therapy.Psychopharmacology of aggression in schizophrenia.Pathways to aggression in schizophrenia affect results of treatmentDisease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders.Concomitant medication of psychoses in a lifetime perspective.CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells.Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion.Pharmacological management of acute and persistent aggression in forensic psychiatry settings.The psychopharmacology of violence: making sensible decisions.Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.Serum concentrations of mood stabilizers are associated with memory, but not other cognitive domains in psychosis spectrum disorders; explorative analyses in a naturalistic setting.Polypharmacy of schizophrenia.β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.The Black Book of Psychotropic Dosing and Monitoring.Polypharmazie bei schizophrenen PsychosenAggression in Psychoses
P2860
Q24186325-2FF23166-FA1A-42A2-A3DF-ACF7146F9F43Q26772965-1EB006CA-8F30-4703-9A71-73DFD6F33E90Q28541404-8E93661D-8F8A-4727-8CB7-2B53B9FC3A37Q34185669-480E586C-C839-4D40-A5CB-3E428B9A75F4Q34682060-2F9E38F3-7F04-4E47-A271-75CFCA232E7EQ34707472-F5EEBB4C-AD54-443A-9890-211ED0980EBAQ34997710-B21D7581-9723-48AD-8FDF-C237972DD609Q35177093-D0B22745-3730-45D0-B3F9-4178F061C256Q35177162-F5514167-33BB-4568-841F-1A3FB4902F06Q35835236-AC6C1E4C-88CF-4AB5-8AB2-607720E86F98Q36420453-3CC7D6EA-1733-402B-8E80-FD84444DC508Q37710652-1EA01E3C-E185-4EF0-8D1E-AAA2EB5BA213Q37804880-68F66A91-B5CB-4CE3-93CE-011095086496Q37963568-BE39EB6F-67ED-480A-A162-6E5E650F781CQ38191300-3C9D8545-CAAD-47EE-B460-84EF0A4E4BEEQ39605188-96F38B7D-2A84-4B4C-8392-2476B0CAC0F9Q41899659-B7503262-AD08-41C5-9FAB-86BC322A49D4Q42133526-04B55346-70BE-43AD-BE7F-1722920DC456Q42976183-4DAF4807-7C7E-4F19-A991-251D37D03AA0Q47642128-59F84906-7923-40FA-BF52-82468A936C0EQ57317032-6B08AC73-889E-4970-B6A3-BEDCF7842F70Q59048862-F98DA995-E65A-45DD-A287-17EAD2EC015A
P2860
Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adjunctive lithium and anticon ...... phrenia: what is the evidence?
@en
Adjunctive lithium and anticon ...... phrenia: what is the evidence?
@nl
type
label
Adjunctive lithium and anticon ...... phrenia: what is the evidence?
@en
Adjunctive lithium and anticon ...... phrenia: what is the evidence?
@nl
prefLabel
Adjunctive lithium and anticon ...... phrenia: what is the evidence?
@en
Adjunctive lithium and anticon ...... phrenia: what is the evidence?
@nl
P2860
P356
P1476
Adjunctive lithium and anticon ...... phrenia: what is the evidence?
@en
P2860
P356
10.1586/14737175.9.1.55
P577
2009-01-01T00:00:00Z